FIELD: pharmacology.
SUBSTANCE: application of 3-methyl-8-(piperazine-1-yl)-7-(thietane-3-yl)-1h-purine-2,6(3H,7H)-dione hydrochloride, or 1,3-dimethyl-8-(piperazine-1-yl)-7-(thietane-3-yl)-1H-purine-2,6(3H,7H)-dione hydrochloride, or 1-butyl-3-methyl-8-(piperazine-1-yl)-7-(thietane-3-yl)-1H-purine-2,6(3H,7H)-dione hydrochloride, or 1-benzyl-3-methyl-8-(piperazine-1-yl)-7-(thietane-3-yl)-1H-purine-2,6(3H,7H)-dione hydrochloride as means with antithrombotic effect by blocking the GP IIb-IIIa platelets receptors.
EFFECT: preparation of a biologically active substance exhibiting an antithrombotic effect by blocking the GP IIb-IIIa platelets receptors.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATMENT AND PREVENTION OF THROMBOSIS | 2017 |
|
RU2662308C1 |
HYDROCHLORIDES OF 1-ALKYL-3-METHYL-8-PIPERAZINO-7-(TIETHANYL-3)XANTHINE SHOWING ANTITHROMBOTIC EFFECT BY BLOCKING GP IIb-IIIa PLATELETS RECEPTORS | 2017 |
|
RU2640579C1 |
AGENT WITH ANTIAGGREGATORY ACTIVITY AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2778686C1 |
METHOD FOR PRODUCING HIGH-FUNCTION THROMBOCYTES | 2016 |
|
RU2724533C2 |
ANTITHROMBOTIC PREPARATION AND METHOD OF PROPHYLAXIS AND TREATMENT OF THROMBOSIS | 2002 |
|
RU2205027C1 |
ANTITHROMBOTIC AZACYCLOALKYLAKANOYL PEPTIDES | 1994 |
|
RU2134695C1 |
TRIAZOLE DERIVATIVES EXHIBITING ANTIAGGREGATORY ACTIVITY | 2021 |
|
RU2770405C1 |
PURINONE COMPOUNDS AS KINASE INHIBITORS | 2013 |
|
RU2655388C2 |
HYDROXYPURINE COMPOUNDS AND WAYS OF THEIR USE | 2015 |
|
RU2673458C1 |
HYDROXYPURINE COMPOUNDS AND USE THEREOF | 2016 |
|
RU2685417C1 |
Authors
Dates
2018-01-31—Published
2016-10-03—Filed